Warning Letters and Notice of Violation Letters to Pharmaceutical Companies:
"These letters are supplied by the CDER Freedom of Information Office (FOI). This page only covers letters issued by Headquarters and the Office of Prescription Drug Promotion (formerly the Division of Drug Marketing, Advertising, and Communications). For District Office warning letters, please see the Main FDA FOI Warning Letters Page.
Some of the letters have been redacted or edited to remove confidential information. Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the recipient of the letter that may have changed the regulatory status of the issues discussed in the letter. "
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment